TY - JOUR
T1 - Factors influencing reduced penetrance and variable expressivity in X-linked dystonia-parkinsonism
AU - Pozojevic, Jelena
AU - Von Holt, Björn Hergen
AU - Westenberger, Ana
N1 - Publisher Copyright:
© 2022 the author(s), published by De Gruyter.
PY - 2022/6/1
Y1 - 2022/6/1
N2 - X-linked dystonia-parkinsonism (XDP) is a neurodegenerative movement disorder that primarily affects adult Filipino men. It is caused by a founder retrotransposon insertion in TAF1 that contains a hexanucleotide repeat, the number of which differs among the patients and correlates with the age at disease onset (AAO) and other clinical parameters. A recent work has identified additional genetic modifiers of age-associated penetrance in XDP, bringing to light the DNA mismatch repair genes MSH3 and PMS2. Despite X-linked recessive inheritance, a minor subset of patients are female, manifesting the disease via various mechanisms such as homozygosity, imbalanced X-chromosome inactivation, or aneuploidy. Here, we summarize and discuss clinical and genetic aspects of XDP, with a focus on variable disease expressivity as a consequence of subtle genetic differences within a seemingly homogenous population of patients.
AB - X-linked dystonia-parkinsonism (XDP) is a neurodegenerative movement disorder that primarily affects adult Filipino men. It is caused by a founder retrotransposon insertion in TAF1 that contains a hexanucleotide repeat, the number of which differs among the patients and correlates with the age at disease onset (AAO) and other clinical parameters. A recent work has identified additional genetic modifiers of age-associated penetrance in XDP, bringing to light the DNA mismatch repair genes MSH3 and PMS2. Despite X-linked recessive inheritance, a minor subset of patients are female, manifesting the disease via various mechanisms such as homozygosity, imbalanced X-chromosome inactivation, or aneuploidy. Here, we summarize and discuss clinical and genetic aspects of XDP, with a focus on variable disease expressivity as a consequence of subtle genetic differences within a seemingly homogenous population of patients.
UR - http://www.scopus.com/inward/record.url?scp=85135913757&partnerID=8YFLogxK
U2 - 10.1515/medgen-2022-2135
DO - 10.1515/medgen-2022-2135
M3 - Journal articles
AN - SCOPUS:85135913757
SN - 0936-5931
VL - 34
SP - 97
EP - 102
JO - Medizinische Genetik
JF - Medizinische Genetik
IS - 2
ER -